Activin a, exendin-4, and glucose stimulate differentiation of human pancreatic ductal cells

Journal of Endocrinology

Volumn 217, Issue 3, 2013, Pages 241-252

  Kim, Hyo Sup ^a   Hong, Seung Hyun ^a,b   Oh, Seung Hoon ^a   Kim, Jae Hyeon ^a   Lee, Myung Shik ^a   Lee, Moon Kyu ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Activin A; Differentiation; Exendin 4; Glucose; Human pancreatic ductal cells

Indexed keywords

ACTIVIN A; EXENDIN 4; GLUCOSE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STREPTOZOCIN DIABETES;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, NUDE; PANCREATIC DUCTS; PEPTIDES; VENOMS;

EID: 84878783546     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0474     Document Type: Article

References (51)

1. Beattie GM, Itkin-Ansari P, Cirulli V, Leibowitz G, Lopez AD, Bossie S, Mally MI, Levine F&Hayek A 1999 Sustained proliferation of PDX-1C cells derived from human islets. Diabetes 48 1013-1019. (doi:10.2337/diabetes.48.5.1013)
2. Bonner-Weir S&Weir GC 2005 New sources of pancreatic b-cells. Nature Biotechnology 23 57-861. (doi:10.1038/nbt1115)
3. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T&Sharma A 2004 The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatric Diabetes 5(Suppl 2) 16-22. (doi:10.1111/ j.1399-543X.2004.00075.x)
4. Brelje TC.,Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG&Sorenson RL 1993 Effect of homologous placental lactogens, prolactins, and growth hormones on islet b-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132 879-887. (doi:10.1210/en.132.2.879)
5. Chen YE&Drucker DJ 1997 Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard. Journal of Biological Chemistry 272 4108-4115. (doi:10.1074/ jbc.272.7.4108)
6. Drucker DJ 1998 Glucagon-like peptides. Diabetes 47 159-169. (doi:10.2337/diabetes.47.2.159)
7. Drucker DJ 2002 Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 531-544. (doi:10.1053/ gast.2002.31068)
8. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B&Raaka BM 2004 Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306 2261-2264. (doi:10.1126/science.1101968)
9. Gmyr V, Kerr-Conte J, Vandewalle B, Proye C, Lefebvre J&Pattou F 2001 Human pancreatic ductal cells: large-scale isolation and expansion. Cell Transplantation 10 109-121.
10. Gmyr V, Belaich S, Muharram G, Lukowiak B, Vandewalle B, Pattou F&Kerr-Conte J 2004 Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9. Biochemical and Biophysical Research Communications 320 27-33. (doi:10.1016/ j.bbrc.2004.05.125)
11. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J&Göke B 1993 Exendin-4 is a high potency agonist and truncated exendin-(9-39)- amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting b-cells. Journal of Biological Chemistry 15 19650-19655.
12. Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ&Egan JM 1999 Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia 42 45-50. (doi:10.1007/s001250051111)
13. Gutniak M, Orskov C, Holst JJ, Ahren B&Efendic S 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. New England Journal of Medicine 326 1316-1322. (doi:10.1056/NEJM199205143 262003)
14. Hardikar AA.,Marcus-Samuels B, Geras-Raaka E, Raaka BM&Gershengorn MC 2003 Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. PNAS 100 7117-7122. (doi:10.1073/pnas.1232230100)
15. Hemmati-Brivanlou A&Melton DA 1994 Inhibition of activin receptor signaling promotes neuralization in Xenopus. Cell 77 273-281. (doi:10.1016/0092-8674(94)90319-0)
16. Ichikawa T, Zhang YQ, Kogure K, Hasegawa Y, Takagi H, MoriM& Kojima I 2001 Transforming growth factor b and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 34 918-925. (doi:10.1053/jhep. 2001.29132)
17. Kanno R, Ogihara T, Igarashi Y, Tanaka Y, Smith SB, Kojima I, German MS, Kawamori R&Watada H 2006 Activin A-induced expression of PAX4 in AR42J-B13 cells involves the increase in transactivation of E47/E12. Biochimica et Biophysica Acta 1759 44-50. (doi:10.1016/ j.bbaexp.2006.01.004)
18. Knudsen LB&Pridal L 1996 Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs.,and it acts as an antagonist on the pancreatic receptor. European Journal of Pharmacology 318 429-435. (doi:10.1016/ S0014-2999(96)00795-9)
19. Kodama S, Toyonaga T, Kondo T, Matsumoto K, Tsuruzoe K, Kawashima J, Goto H, Kume K, Kume S, Sakakida M et al. 2005 Enhanced expression of PDX-1 and Ngn3 by exendin-4 during b cell regeneration in STZ-treated mice. Biochemical and Biophysical Research Communications 327 1170-1178. (doi:10.1016/j.bbrc.2004.12.120)
20. Lefebvre VH.,Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG&Bouwens L 1998 Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for b-cells. Diabetes 47 134-137. (doi:10.2337/diabetes. 47.1.134)
21. Li L., Yi Z, Seno M&Kojima I 2004 Activin A and betacellulin: effect on regeneration of pancreatic b-cells in neonatal streptozotocin-treated rats. Diabetes 53 608-615. (doi:10.2337/diabetes.53.3.608)
22. Maehr R.,Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibelc RL&Melton DA 2009 Generation of pluripotent stem cells from patients with type 1 diabetes. PNAS 106 15768-15773. (doi:10.1073/ pnas.0906894106)
23. Mashima H.,Ohnishi H, Wakabayashi K, Mine T, Miyagawa J, Hanafusa T, Seno M, Yamada H&Kojima I 1996 Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. Journal of Clinical Investigation 97 1647-1654. (doi:10.1172/JCI118591)
24. Mojsov S, Weir GC&Habener JF 1987 Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. Journal of Clinical Investigation 79 616-619. (doi:10.1172/JCI112855)
25. Moriya N.,Komazaki S, Takahashi S, Yokota C&Asashima M 2000 In vitro pancreas formation from Xenopus ectoderm treated with activin and retinoic acid. Development, Growth&Differentiation 42 593-602. (doi:10.1046/j.1440-169x.2000.00542.x)
26. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R&Creutzfeldt W 1993 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 91 301-307. (doi:10.1172/JCI116186)
27. Ogihara T, Watada H, Kanno R, Ikeda F, Nomiyama T, Tanaka Y, Nakao A, German MS, Kojima I&Kawamori R 2003 p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells. Journal of Biological Chemistry 278 21693-21700. (doi:10.1074/ jbc.M302684200)
28. Ouziel-Yahalom L, Zalzman M, Anker-Kitai L, Knoller S, Bar Y, Glandt M, Herold K&Efrat S 2006 Expansion and redifferentiation of adult human pancreatic islet cells. Biochemical and Biophysical Research Communications 341 291-298. (doi:10.1016/ j.bbrc.2005.12.187)
29. Park MK, Han C, Lee KH, Hong SH, Kim HS, Lee YJ, Jeong IK, Noh JH, Yang TY, LeeMS et al. 2007 Effects of activin A on pancreatic ductal cells in streptozotocin-induced diabetic rats. Transplantation 83 925-930. (doi:10.1097/01.tp.0000259978.62139.9d)
30. Ricordi C, Lacy PE, Finke EH, Olack BJ&Scharp DW 1988 Automated method for isolation of human pancreatic islets. Diabetes 37 413-420. (doi:10.2337/diabetes.37.4.413)
31. Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R et al. 1990 Islet isolation assessment in man and large animals. Acta Diabetologica Latina 27 185-195. (doi:10.1007/BF02581331)
32. Robertson GS.,Chadwick DR, Contractor H, James RF, Bell PR&London NJ 1993 The use of continuous density gradients for the assessment of islet and exocrine tissue densities and islet purification. Acta Diabetologica 30 175-180. (doi:10.1007/BF00572864)
33. Russ H.A.,Ravassard P, Kerr-Conte J, Pattou F&Efrat S 2009 Epithelial- mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic b cells. PLoS ONE 4 e6417. (doi:10.1371/ journal.pone.0006417)
34. Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC et al. 2004 Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Laboratory Investigation 84 1245-1258. (doi:10.1038/labinvest.3700156)
35. Sudre B, Broqua P, White RB, Ashworth D, Evans DM, Haigh R, Junien JL&Aubert ML 2002 Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 51 1461-1469. (doi:10.2337/ diabetes.51.5.1461)
36. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC&Zhang Y 2008 Generation of insulin-secreting islet-like clusters from human skin fibroblasts. Journal of Biological Chemistry 283 31601-31607. (doi:10.1074/jbc.M806597200)
37. Thorens B., Porret A, Buhler L, Deng SP, Morel P&Widmann C 1993 Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42 1678-1682. (doi:10.2337/ diabetes.42.11.1678)
38. Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA&Bloom SR 1997 Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulindependent diabetes mellitus. European Journal of Clinical Investigation 27 533-536. (doi:10.1046/j.1365-2362.1997.1490691.x)
39. Tourrel C, Bailbe D, Meile MJ, Kergoat M&Portha B 2001 Glucagon-like peptide-1 and exendin-4 stimulate b-cell neogenesis in streptozotocintreated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50 1562-1570. (doi:10.2337/ diabetes.50.7.1562)
40. Tuch BE&Chen J 1993 Resistance of the human fetal b-cell to the toxic effect of multiple low-dose streptozotocin. Pancreas 8 305-311. (doi:10.1097/00006676-199305000-00004)
41. Tuch BE, Turtle JR&Simeonovic CJ 1989 Streptozotocin is not toxic to the human fetal b-cell. Diabetologia 32 678-684. (doi:10.1007/ BF00274256)
42. Ueda Y 2000 Activin A increases Pax4 gene expression in pancreatic b cell lines. FEBS Letters 480 101-105. (doi:10.1016/S0014-5793(00) 01914-1)
43. Ulianich L, Garbi C, Treglia AS, Punzi D, Miele C, Raciti GA, Beguinot F, Consiglio E&Di Jeso B 2008 ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC CI3 thyroid cells. Journal of Cell Science 121 477-486. (doi:10.1242/ jcs.017202)
44. Xu G, Stoffers DA, Habener JF&Bonner-Weir S 1999 Exendin-4 stimulates both b-cell replication and neogenesis, resulting in increased b-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48 2270-2276. (doi:10.2337/diabetes.48.12.2270)
45. Yamada G, Kioussi C, Schubert FR, Eto Y, Chowdhury K, Pituello F&Gruss P 1994 Regulated expression of Brachyury(T), Nkx1.1 and Pax genes in embryoid bodies. Biochemical and Biophysical Research Communications 199 552-563. (doi:10.1006/bbrc.1994.1264)
46. Yamaoka T, Idehara C, Yano M, Matsushita T, Yamada T, Ii S, Moritani M, Hata J, Sugino H, Noji S et al. 1998 Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. Journal of Clinical Investigation 102 294-301. (doi:10.1172/ JCI2769)
47. Yang H&Wright JR Jr 2002 Human b cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143 2491-2495. (doi:10.1210/ en.143.7.2491REF5=10.1074/jbc.272.7.4108)
48. Yuan S, Rosenberg L, Paraskevas S, Agapitos D&Duguid WP 1996 Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61 67-75. (doi:10.1046/ j.1432-0436.1996.6110067.x)
49. Yue F.,Cui L, Johkura K, Ogiwara N&Sasaki K 2006 Glucagon-like peptide-1 differentiation of primate embryonic stem cells into insulin-producing cells. Tissue Engineering 12 2105-2116. (doi:10.1089/ten.2006.12.2105)
50. Zhang YQ, Kanzaki M, Mashima H, Mine T&Kojima I 1996 Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes. Hepatology 23 288-293. (doi:10.1002/hep.510230214)
51. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y&Deng H 2009 Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Research 19 429-438. (doi:10.1038/cr.2009.28)